Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP629063.RAjFWSQXsuyPgcbBVgbEVLmJkWHydeNQNQGMvJBDtcNlw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP629063.RAjFWSQXsuyPgcbBVgbEVLmJkWHydeNQNQGMvJBDtcNlw130_assertion type Assertion NP629063.RAjFWSQXsuyPgcbBVgbEVLmJkWHydeNQNQGMvJBDtcNlw130_head.
- NP629063.RAjFWSQXsuyPgcbBVgbEVLmJkWHydeNQNQGMvJBDtcNlw130_assertion description "[Human breast cancers with malignant choline metabolite profiles consisting of low GPC and high PC levels highly co-expressed GDPD5, choline kinase alpha (CHKA) and phosphatidylcholine-specific phospholipase D1 (PLD1), whereas cancers containing high GPC and relatively low PC levels displayed low co-expression of GDPD5, CHKA and PLD1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP629063.RAjFWSQXsuyPgcbBVgbEVLmJkWHydeNQNQGMvJBDtcNlw130_provenance.
- NP629063.RAjFWSQXsuyPgcbBVgbEVLmJkWHydeNQNQGMvJBDtcNlw130_assertion evidence source_evidence_literature NP629063.RAjFWSQXsuyPgcbBVgbEVLmJkWHydeNQNQGMvJBDtcNlw130_provenance.
- NP629063.RAjFWSQXsuyPgcbBVgbEVLmJkWHydeNQNQGMvJBDtcNlw130_assertion SIO_000772 22279038 NP629063.RAjFWSQXsuyPgcbBVgbEVLmJkWHydeNQNQGMvJBDtcNlw130_provenance.
- NP629063.RAjFWSQXsuyPgcbBVgbEVLmJkWHydeNQNQGMvJBDtcNlw130_assertion wasDerivedFrom befree-20140225 NP629063.RAjFWSQXsuyPgcbBVgbEVLmJkWHydeNQNQGMvJBDtcNlw130_provenance.
- NP629063.RAjFWSQXsuyPgcbBVgbEVLmJkWHydeNQNQGMvJBDtcNlw130_assertion wasGeneratedBy ECO_0000203 NP629063.RAjFWSQXsuyPgcbBVgbEVLmJkWHydeNQNQGMvJBDtcNlw130_provenance.